| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
BACE (Bendamustine, Cytarabine, Cyclophosphamide and Etoposide) conditioning regime for patients with lymphoma undergoing autologous stem cell transplant
|
Chakrabartty, Joydeep
|
|
|
18 |
2 |
p. 136-141
|
artikel
|
| 2 |
Best of ESMO 2024: gynecologic cancers
|
Polterauer, Stephan
|
|
|
18 |
2 |
p. 71-74
|
artikel
|
| 3 |
Best of ESMO: pan-tumor highlights
|
Füreder, Thorsten
|
|
|
18 |
2 |
p. 82-85
|
artikel
|
| 4 |
Blinatumomab is changing the standard of care paradigms of newly diagnosed and relapsed pediatric B-cell acute lymphoblastic leukemia
|
Attarbaschi, Andishe
|
|
|
18 |
2 |
p. 104-107
|
artikel
|
| 5 |
CRLF2 expression associated with poor outcome in Philadelphia-negative acute lymphoblastic leukemia
|
El-Afifi, Amal M.
|
|
|
18 |
2 |
p. 129-135
|
artikel
|
| 6 |
Cure for multiple myeloma?
|
Podar, Klaus
|
|
|
18 |
2 |
p. 108-115
|
artikel
|
| 7 |
Current and future pharmacological therapies for extensive-stage small-cell lung cancer
|
Schöche, Johannes
|
|
|
18 |
2 |
p. 116-124
|
artikel
|
| 8 |
ESMO 2024
|
Bartsch, Rupert
|
|
|
18 |
2 |
p. 80-81
|
artikel
|
| 9 |
ESMO 2024: highlights in breast cancer
|
Udovica, Simon
|
|
|
18 |
2 |
p. 75-79
|
artikel
|
| 10 |
Evaluating antifungal prophylaxis strategies in pediatric acute myeloid leukemia: a retrospective, single-center analysis of amphotericin B, itraconazole, and voriconazole
|
Cvrtak, Anna
|
|
|
18 |
2 |
p. 142-149
|
artikel
|
| 11 |
Mind the gap in clinical practice guidelines—how I treat CLL patients with unmutated IGHV status
|
Prochazka, Katharina
|
|
|
18 |
2 |
p. 97-100
|
artikel
|
| 12 |
Novel mutated Dubin–Johnson syndrome diagnosed during acute promyelocytic leukemia treatment
|
Afacan Öztürk, Hacer Berna
|
|
|
18 |
2 |
p. 125-128
|
artikel
|
| 13 |
Optimizing disease risk stratification and clinical outcomes in chronic lymphocytic leukemia 2025
|
Bohn, Jan-Paul
|
|
|
18 |
2 |
p. 69-70
|
artikel
|
| 14 |
Prognostic tools and risk factors in early-stage CLL—time for a change in treatment paradigm?
|
Bartkowiak, Martyna
|
|
|
18 |
2 |
p. 86-91
|
artikel
|
| 15 |
The management of modern targeted therapy for CLL in a patient with significant cardiac comorbidities—a case report
|
Spanberger, Thomas
|
|
|
18 |
2 |
p. 101-103
|
artikel
|
| 16 |
Too frail or not too frail? Prognosis and treatment options in older CLL patients
|
Simon, Florian
|
|
|
18 |
2 |
p. 92-96
|
artikel
|
Tijdschrift beschrijving